Schwegman, Lundberg, Woessner & Kluth Company Profile

14:53 EDT 21st March 2018 | BioPortfolio

In 1993, Micheal Schwegman, Steven Lundberg, Warren Woessner, and Daniel Kluth left a prominent Minneapolis IP law firm to establish their own firm. They recognized that conventional IP firms tended to concentrate significantly more resources on litigation than on patent prosecution. As a result, many firms were hindering the ability of skilled patent prosecutors to do their best work, and therefore possibly shortchanging their clients.The founders developed a new IP law firm model, in which obtaining the strongest patents is the sole focus of the firm. They founded SLWK to provide patent preparation and prosecution services for emerging and established corporations and research institutions.Today, Schwegman, Lundberg, Woessner & Kluth has grown to over 70 attorneys and represents a spectrum of Fortune 500 companies and major universities that are leaders in high technology. The firm obtained over 3,000 patents in its first ten years.Over 70 attorneys make up the SLWK team. The firm has twenty-one shareholders, which include Micheal L. Schwegman, Steven W. Lundberg, Warren D. Woessner, Daniel J. Kluth, Bradley A. Forrest, Thomas F. Brennan, A. James Nelson, Timothy E. Bianchi, Janet E. Embretson, Richard E. Billion, Eduardo E. Drake, Janal M. Kalis, Ann M. McCrackin, Catherine I. Klima-Silberg, Andre Marais, Suneel Arora, Gary Speier, Garth Vivier, John Sumner, Michael Lynch, and Robin Chadwick. The firm also has eight officers, which include John Dahl, David Black, Peter Maki, Joe Mehrle, Mark Muller, David Peterson, Marv Beekman, and Tim Clise.It is the mission of SLWK to be the highest quality provider of intellectual property services.To further its mission of providing cost-effective, high-quality protection for its clients' intellectual property, the firm concentrates solely on patent prosecution and refrains from the active conduct of litigation. It does, however, support litigation through opinion work, IP audits and expert witness services. The firm also developed and employs sophisticated proprietary systems to manage and control patent preparation and prosecution.


1600 TCF Tower 121 South Eighth Street
United States of America


Phone: (612) 373-6900

News Articles [10 Associated News Articles listed on BioPortfolio]

CRISPR Therapeutics’ Lundberg Steps Down as Chief Scientific Officer

Bill Lundberg is leaving his position as chief scientific officer of CRISPR Therapeutics (NASDAQ: CRSP). CRISPR Therapeutics, which has operations in Switzerland and Cambridge, MA, said that Lundberg ...

CRISPR Therapeutics Announces Transition of Bill Lundberg, MD

ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines f...

#news #biotech CRISPR CSO departs as Celgene continues to sell stock

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: CRISPR CSO departs as Celgene continues to sell stock .Bill Lundberg, M.D., h...

There Is No Medical Response to Nuclear War

Dr Lundberg discusses practical prescriptions for preventing nuclear war, including four of his own. Medscape Internal Medicine

Gun Sense or Non-sense?

These days, the only limiting parameter to gun ownership seems to be how many people you wish to kill in a brief time, says Dr Lundberg. Medscape Internal Medicine

An Unusually Happy Holiday Blog from 'Scrooge'

Dr Lundberg offers an atypically celebratory holiday message about the world's first free, for-credit university, NextGenU. Medscape Internal Medicine

Musing on Sexual Ethics

Dr George Lundberg urges discussion on modern sexual ethics. Medscape Internal Medicine

Inom 2 tim ska Apotekets kunder ha läkemedlet

Apotekets marknadsdirektör Eric Lundberg meddelade en tuff nyhet för nätapoteken. Nu ska kunderna ha sina läkemedel de beställer på nätet, inom två timmar.

Drugs and Medications [0 Results]


PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Comments on the "2017 Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups". Points of concern.

We have read with interest the report on the 2017 European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria for adult and juvenile idiopathic inflammatory...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Study For Evaluating The Value Of A Multi Biomarker Approach In Metastatic GEP-NETS

This exploratory study aims to evaluate the diagnostic, prognostic and response predictive value of a multi biomarker strategy in patients with Neuroendocrine Tumors (NETs) originating fro...

Companies [2 Associated Companies listed on BioPortfolio]

Schwegman, Lundberg, Woessner & Kluth

In 1993, Micheal Schwegman, Steven Lundberg, Warren Woessner, and Daniel Kluth left a prominent Minneapolis IP law firm to establish their own firm. They recognized that conventional IP firms tended t...

Lundberg Family Farms

Since 1937, the Lundberg Family has been farming rice and producing rice products at their farms in the Sacramento Valley. Now led by its third generation, Lundberg Family Farms u...

More Information about "Schwegman, Lundberg, Woessner & Kluth" on BioPortfolio

We have published hundreds of Schwegman, Lundberg, Woessner & Kluth news stories on BioPortfolio along with dozens of Schwegman, Lundberg, Woessner & Kluth Clinical Trials and PubMed Articles about Schwegman, Lundberg, Woessner & Kluth for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Schwegman, Lundberg, Woessner & Kluth Companies in our database. You can also find out about relevant Schwegman, Lundberg, Woessner & Kluth Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record